| 1 | [SID99454959] | Active | Potency | 4.1095 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | Potency | 4.1095 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 2 | [SID99454959] | Active | Potency | 4.1095 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | Potency | 4.1095 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 3 | [SID99454959] | Active | Potency | 4.1095 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | Potency | 4.1095 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 4 | [SID99454959] | Active | Potency | 4.4668 | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | Potency | 4.4668 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 5 | [SID99454959] | Active | Potency | 4.4668 | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | Potency | 4.4668 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 6 | [SID99454959] | Active | IC50 | 5 | Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3):Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) [AID624395, Type: confirmatory] | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | IC50 | 5 [uM] | | BioAssay | Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3):Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) | | AID | 624395 | | BioAssay type | confirmatory | | Target | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] | | PubMed | | | Data Table |  |
|
| 7 | [SID99454959] | Active | IC50 | 7.717 | Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624394, Type: confirmatory] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | IC50 | 7.717 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624394 | | BioAssay type | confirmatory | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 8 | [SID99454959] | Active | IC50 | 7.717 | Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624394, Type: confirmatory] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | IC50 | 7.717 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624394 | | BioAssay type | confirmatory | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 9 | [SID99454959] | Active | IC50 | 7.717 | Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624394, Type: confirmatory] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | IC50 | 7.717 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624394 | | BioAssay type | confirmatory | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 10 | [SID99454959] | Active | Potency | 10 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 11 | [SID99454959] | Active | Potency | 10 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 12 | [SID99454959] | Active | Potency | 10.3225 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | Potency | 10.3225 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID99454959] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 14 | [SID99454959] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 15 | [SID99454959] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 16 | [SID99454959] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624378, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624378 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 17 | [SID99454959] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624378, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624378 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 18 | [SID99454959] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624378, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624378 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 19 | [SID99454959] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) [AID686940, Type: screening] | NR2F2 gene product [Homo sapiens] [gi:14149746] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 686940 | | BioAssay type | screening | | Target | NR2F2 gene product [Homo sapiens] [gi:14149746] | | PubMed | | | Data Table |  |
|
| 20 | [SID99454959] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) [AID686940, Type: screening] | NR2F2 gene product [Homo sapiens] [gi:14149746] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 686940 | | BioAssay type | screening | | Target | NR2F2 gene product [Homo sapiens] [gi:14149746] | | PubMed | | | Data Table |  |
|
| 21 | [SID99454959] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 22 | [SID99454959] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 23 | [SID99454959] | Active | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) [AID624377, Type: screening] | ASAP1 gene product [Homo sapiens] [gi:351542238] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) | | AID | 624377 | | BioAssay type | screening | | Target | ASAP1 gene product [Homo sapiens] [gi:351542238] | | PubMed | | | Data Table |  |
|
| 24 | [SID99454959] | Inactive | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) [AID624431, Type: screening] | ASAP1 gene product [Homo sapiens] [gi:351542238] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) | | AID | 624431 | | BioAssay type | screening | | Target | ASAP1 gene product [Homo sapiens] [gi:351542238] | | PubMed | | | Data Table |  |
|
| 25 | [SID99454959] | Inactive | | | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) [AID602281, Type: screening] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) | | AID | 602281 | | BioAssay type | screening | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 26 | [SID99454959] | Inactive | | | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity [AID652197, Type: screening] | ERAP1 protein [Homo sapiens] [gi:21315078] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652197 | | BioAssay type | screening | | Target | ERAP1 protein [Homo sapiens] [gi:21315078] | | PubMed | | | Data Table |  |
|
| 27 | [SID99454959] | Inactive | | | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity [AID652197, Type: screening] | ERAP1 protein [Homo sapiens] [gi:21315078] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652197 | | BioAssay type | screening | | Target | ERAP1 protein [Homo sapiens] [gi:21315078] | | PubMed | | | Data Table |  |
|
| 28 | [SID99454959] | Inactive | | | qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1) [AID624414, Type: screening] | MCOLN1 gene product [Homo sapiens] [gi:10092597] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1) | | AID | 624414 | | BioAssay type | screening | | Target | MCOLN1 gene product [Homo sapiens] [gi:10092597] | | PubMed | | | Data Table |  |
|
| 29 | [SID99454959] | Inactive | Potency | | qHTS for Inhibitors of Vif-A3G Interactions: qHTS [AID602310, Type: confirmatory] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Vif-A3G Interactions: qHTS | | AID | 602310 | | BioAssay type | confirmatory | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 30 | [SID99454959] | Inactive | | | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay [AID588621, Type: screening] | PTPN5 gene product [Homo sapiens] [gi:90652859] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay | | AID | 588621 | | BioAssay type | screening | | Target | PTPN5 gene product [Homo sapiens] [gi:90652859] | | PubMed | | | Data Table |  |
|
| 31 | [SID99454959] | Inactive | | | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay [AID588621, Type: screening] | PTPN5 gene product [Homo sapiens] [gi:90652859] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay | | AID | 588621 | | BioAssay type | screening | | Target | PTPN5 gene product [Homo sapiens] [gi:90652859] | | PubMed | | | Data Table |  |
|
| 32 | [SID99454959] | Inactive | | | uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8) [AID602440, Type: screening] | SENP8 gene product [Homo sapiens] [gi:262118306] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8) | | AID | 602440 | | BioAssay type | screening | | Target | SENP8 gene product [Homo sapiens] [gi:262118306] | | PubMed | | | Data Table |  |
|
| 33 | [SID99454959] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) [AID624467, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624467 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 34 | [SID99454959] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) [AID624467, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624467 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 35 | [SID99454959] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 36 | [SID99454959] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 37 | [SID99454959] | Inactive | Potency | | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 38 | [SID99454959] | Inactive | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 39 | [SID99454959] | Inactive | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 40 | [SID99454959] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter [AID540364, Type: screening] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter | | AID | 540364 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID99454959] | Inactive | | | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts [AID588335, Type: screening] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts | | AID | 588335 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID99454959] | Inactive | | | Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity [AID588436, Type: screening] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity | | AID | 588436 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID99454959] | Inactive | | | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID651800, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 651800 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 44 | [SID99454959] | Inactive | | | Luminescence-based cell-based high throughput confirmation assay to identify inhibitors of COUP-TFII (NR2F2) [AID687008, Type: screening] | NR2F2 gene product [Homo sapiens] [gi:14149746] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based high throughput confirmation assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 687008 | | BioAssay type | screening | | Target | NR2F2 gene product [Homo sapiens] [gi:14149746] | | PubMed | | | Data Table |  |
|
| 45 | [SID99454959] | Inactive | | | Luminescence-based cell-based high throughput confirmation assay to identify inhibitors of COUP-TFII (NR2F2) [AID687008, Type: screening] | NR2F2 gene product [Homo sapiens] [gi:14149746] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based high throughput confirmation assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 687008 | | BioAssay type | screening | | Target | NR2F2 gene product [Homo sapiens] [gi:14149746] | | PubMed | | | Data Table |  |
|
| 46 | [SID99454959] | Inactive | | | uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay [AID588489, Type: screening] | polyadenylate-binding protein 1 [Homo sapiens] [gi:46367787] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay | | AID | 588489 | | BioAssay type | screening | | Target | polyadenylate-binding protein 1 [Homo sapiens] [gi:46367787] | | PubMed | | | Data Table |  |
|
| 47 | [SID99454959] | Inactive | | | Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity [AID651658, Type: screening] | FGF22 gene product [Homo sapiens] [gi:10190672] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651658 | | BioAssay type | screening | | Target | FGF22 gene product [Homo sapiens] [gi:10190672] | | PubMed | | | Data Table |  |
|
| 48 | [SID99454959] | Inactive | | | High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity [AID651819, Type: screening] | TRIC [Homo sapiens] [gi:83758679] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity | | AID | 651819 | | BioAssay type | screening | | Target | TRIC [Homo sapiens] [gi:83758679] | | PubMed | | | Data Table |  |
|
| 49 | [SID99454959] | Inactive | | | Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity [AID602346, Type: screening] | Vif [Human immunodeficiency virus 1] [gi:9629361] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602346 | | BioAssay type | screening | | Target | Vif [Human immunodeficiency virus 1] [gi:9629361] | | PubMed | | | Data Table |  |
|
| 50 | [SID99454959] | Inactive | | | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate [AID651958, Type: screening] | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 99454959 | | CID | 46943077 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate | | AID | 651958 | | BioAssay type | screening | | Target | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] | | PubMed | | | Data Table |  |
|